Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Chi Lin

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2013
Reply to S. ValeChia-Chi Lin, Jann-Yuan Wang, Yeong-Shiau Pu
Anticancer Research|August 5, 2006
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case studyChia-Chi Lin, Chih-Hung Hsu, Yeong-Shiau Pu
Journal of Hazardous Materials|January 16, 2014
Zinc oxide nanoparticles alter hatching and larval locomotor activity in zebrafish (Danio rerio)Te-Hao Chen, Chia-Chi Lin, Pei-Jie Meng
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLCRené H Medema, Chia-Chi Lin, James Chih-Hsin Yang
Current Opinion in Oncology|January 23, 2015
Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancerBin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Expert Opinion on Pharmacotherapy|May 5, 2018
Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials?Bin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Future Oncology (London, England)|July 11, 2013
EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancerHsiang-Fong Kao, Chia-Chi Lin, James Chih-Hsin Yang
Current Oncology Reports|February 1, 2017
Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of AfatinibBin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Drugs|March 13, 2013
First-line management of EGFR-mutated advanced lung adenocarcinoma: recent developmentsBin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Virus Research|August 31, 2014
Reduced genetic distance and high replication levels increase the RNA recombination rate of hepatitis delta virusChia-Chi Lin, Zhi-Wei Yang, Shan-Bei Iang, et al.
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2013
Reply to S. ValeChia-Chi Lin, Jann-Yuan Wang, Yeong-Shiau Pu
Anticancer Research|August 5, 2006
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case studyChia-Chi Lin, Chih-Hung Hsu, Yeong-Shiau Pu
Journal of Hazardous Materials|January 16, 2014
Zinc oxide nanoparticles alter hatching and larval locomotor activity in zebrafish (Danio rerio)Te-Hao Chen, Chia-Chi Lin, Pei-Jie Meng
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLCRené H Medema, Chia-Chi Lin, James Chih-Hsin Yang
Current Opinion in Oncology|January 23, 2015
Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancerBin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Expert Opinion on Pharmacotherapy|May 5, 2018
Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials?Bin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Future Oncology (London, England)|July 11, 2013
EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancerHsiang-Fong Kao, Chia-Chi Lin, James Chih-Hsin Yang
Current Oncology Reports|February 1, 2017
Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of AfatinibBin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Drugs|March 13, 2013
First-line management of EGFR-mutated advanced lung adenocarcinoma: recent developmentsBin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Virus Research|August 31, 2014
Reduced genetic distance and high replication levels increase the RNA recombination rate of hepatitis delta virusChia-Chi Lin, Zhi-Wei Yang, Shan-Bei Iang, et al.
Pageof 24